RPH Group (MJM Pharmaceuticals and Radioprotection Ltd.)

www.gruporph.com.br
Drug Industry
Midsize

MJM is the Brazilian leader in the production and commercialization of lyophilized kits for use in nuclear medicine (radiopharmaceuticals). It is the only Brazilian private company that holds the Good Manufacturing Practices Certificate, issued by Anvisa, for the production of the aforementioned product. Another group company, RPH Radiofarmácia Centralizada, installed the first centralized radiopharmacy in the country. Although pioneering in Brazil, this work model with centralized radiopharmacies is enshrined in the health systems of countries with the highest quality concept in the area. The RPH Group delivers complete solutions for doctors, clinics and hospitals, regarding Nuclear Medicine, through our three business units. RPH Pharma: pharmaceutical industry. RPH Serviços: offers training and management services in Radiopharmacy. RPH Central Pharma: Centralized radiopharmacy, which handles and distributes individual doses of radiopharmaceuticals ready for administration to patients.

Partnerships sought:

1. Technological partnerships and possible joint ventures with companies in the sector
2. There is a project to increase exports of radiopharmaceuticals, seeking commercial partnerships with local agents